11 min listen
The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resourc…
FromVJHemOnc Podcast
The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resourc…
FromVJHemOnc Podcast
ratings:
Length:
57 minutes
Released:
Jul 28, 2020
Format:
Podcast episode
Description
The ongoing COVID-19 pandemic caused by SARS-CoV-2 is an international public health issue and patients with cancer consistently demonstrate poorer...
The post The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation appeared first on VJHemOnc.
The post The HemOnc & COVID-19 Sessions: treating hematological malignancies, reducing nosocomial COVID-19 infections, clinical trial participation and resource allocation appeared first on VJHemOnc.
Released:
Jul 28, 2020
Format:
Podcast episode
Titles in the series (100)
Revolutionary immunotherapies for lymphoma: Immunotherapy has emerged in recent years as an effective novel treatment for lymphoma, with studies constantly striving to identify new... by VJHemOnc Podcast